Is Pembrolizumab Appropriate Before EGFR TKI Therapy in Lung Cancer?

Bryant FurlowJun 3, 2018Administering pembrolizumab before EGFR TKIs may be inappropriate for TKI-naive patients with EGFR-mutant NSCLC.

Source: CancerNetwork - June 3, 2018 Category: Cancer & Oncology Authors: A Source Type: news